Home/ Supplements/ Melatonin/ Dual Spectrum Melatonin 5 mg

Dual Spectrum Melatonin 5 mg

product on market Tablet or Pill Nature's Bounty Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Melatonin is a hormone used to support sleep onset and regulate circadian rhythms. There is strong evidence supporting its efficacy for short-term sleep disturbances and jet lag. This ingredient is generally well-tolerated and maintains a high safety profile.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Dual Spectrum Melatonin 5 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

5 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Dicalcium Phosphate Vegetable Cellulose Contains <2% of:
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: For adults, take one (1) tablet only at bedtime as Melatonin may produce drowsiness.

Limit use to two months with a break of one week.

Warnings & Precautions

Not intended for use by persons under the age of 18. Keep out of reach of children.

Do not use if seal under cap is broken or missing.

WARNING: Not intended for use by pregnant or nursing women. If you are taking any medications or have any medical condition, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur. Do not drive, operate machinery or consume alcohol when taking this product. Limit use to two months with a break of one week.

Formulation Notes

100% Drug Free

Non-GMO, No Artificial Flavor, No Artificial Sweetener, No Preservatives, No Sugar, No Starch, No Milk, No Lactose, No Soy, No Gluten, No Wheat, No Yeast, No Fish. Sodium Free.

Suitable for Vegetarians.

Additional Information

Store at room temperature.

Made In The USA with select ingredients from around the world

Clinically Studied Guaranteed Quality Laboratory Tested

Each bi-layer tablet features ISR Technology, a specialized delivery mechanism that provides the benefits of immediate and sustained release in one convenient tablet.

Nutrition Questions or Comments? Call 1-800-433-2990 Mon. - Sat. 9 AM - 7 PM ET Join our Loyalty Program at NaturesBountyRewards.com

Prod. No. 53098 03C B53098

Fall Asleep Faster, Stay Asleep Longer

BI-LAYER Quick Release Layer Extended Release Layer

Metadata

Product Details

UPC / SKU0 74312 53098 2
DSLD Entry Date2016-06-24
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
DSLD ID62274
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.